Assay Development
Elevating diagnostic precision with advanced assay development
Africa’s vast genetic diversity is the highest in the world. Metaphor leverages this to develop cost-effective, robust diagnostic assays tailored to the region. We address critical diagnostic insufficiencies while collaborating with global innovators to integrate Africa’s population into their diagnostic innovations for broader applicability.
Design And Feasibility Studies
Our services cover an extensive range of assay formats
Molecular Assays (PCR, qPCR)
Precision genetic testing to identify pathogens or genetic mutations.
Liquid Biopsy Assays
Biomarker analysis in blood or other body fluids to detect cancer and monitor disease progression non-invasively.
Lateral Flow Assays
Ideal for rapid, point-of-care testing.
ELISA
For highly sensitive detection of antigens or antibodies.
From Concept to Reality
We begin with a deep dive into the client’s requirements. Our R&D team conducts thorough feasibility studies to assess various assay formats and methodologies and ensure that the proposed assay aligns perfectly with the diagnostic goals.
Crafting the perfect assay
Once the design is finalized, our skilled scientists develop and optimize the assay to ensure it meets all performance criteria. This phase includes:
Primer and Probe Design
Protocol Development
Prototype Development
Ensuring reliability
Validation is critical to the reliability and regulatory compliance of diagnostic assays. At Metaphor, we adhere to guidelines from the FDA, CAP and ISO.
Sensitivity and Specificity Testing
Robustness and Reproducibility
.jpg)
Comprehensive Documentation
Expertise and advanced technologies
Our capabilities
Cutting-Edge Platforms
Our state-of-the-art technology platforms support high-throughput screening, multiple readout options, and a wide array of diagnostic applications.
